Journal of Nuclear Medicine

Services claiming to be JNM are soliciting authors, editors, and reviewers. Read more to protect yourself.

MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy
177Lu-DOTATATE in Combination with PARP Inhibitor Olaparib Is Feasible in Patients with Somatostatin-Positive Tumors: Results from the LuPARP Phase I Trial
JNM Podcast Episode 10 – Understanding Metabolic PET Markers Beyond SUV
Entities are misrepresenting themselves as JNM. Read more on how to protect yourself.

Published Ahead of Print

You have access
Rethinking Dosimetry: A European Perspective
Johannes Tran-Gia, Francesco Cicone, Michel Koole, Francesco Giammarile, Jonathan Gear, Emmanuel Deshayes, Pablo Minguez Gabiña, Marta Cremonesi, Jonathan Wadsley, Peter Bernhardt, Manuel Bardiès, Silvano Gnesin, Mattias Sandström, Ulrike Garske-Román, Mona-Elisabeth R. Revheim, Frederik A. Verburg, Mark Konijnenberg, Bernd Joachim Krause, Michael Lassmann and Caroline Stokke

Journal of Nuclear Medicine May 22, 2025, jnumed.124.269378; DOI: https://doi.org/10.2967/jnumed.124.269378
You have access
¹⁷⁷Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
Swayamjeet Satapathy, Chandan K. Das, Shikha Goyal, Ashwani Sood, Kannan Periasamy, Piyush Aggarwal, Komal Preet, Shrawan K. Singh, Ravimohan S. Mavuduru, Girdhar S. Bora, Aditya P. Sharma, Gaurav Prakash, Rajender Kumar, Harmandeep Singh and Bhagwant R. Mittal

Journal of Nuclear Medicine May 22, 2025, jnumed.125.269913; DOI: https://doi.org/10.2967/jnumed.125.269913
You have access
Redefining Nuclear Medicine: “Biodistribution” Should Be the Core Concept
Celso Dario Ramos

Journal of Nuclear Medicine May 22, 2025, jnumed.125.270245; DOI: https://doi.org/10.2967/jnumed.125.270245
You have access
[¹⁸F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study
David L. Chan, Aimee Hayes, Ioannis Karfis, Alice Conner, Magdalena Mileva, Elizabeth Bernard, Shaunak Navalkissoor, Gopinath Gnanasekaran, Stephen J. Clarke, Paul J. Roach, Patrick Flamen, Martyn E. Caplin, Nick Pavlakis, Christos Toumpanakis and Dale L. Bailey

Journal of Nuclear Medicine May 22, 2025, jnumed.124.269031; DOI: https://doi.org/10.2967/jnumed.124.269031
You have access
Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with ²²³Ra Therapy in Daily Practice
Joost H.H.M. van Riel, Maarten L. Donswijk, Christel Brouwer, Winald R. Gerritsen, T.T. Ha Tan-Phan, Paul W.L. Thimister, Walter Noordzij, Erik T. Te Beek, Laurence J.C. van Warmerdam, Andries M. Bergman, Inge M. van Oort, Dirk N.J. Wyndaele and Maarten J. van der Doelen

Journal of Nuclear Medicine May 22, 2025, jnumed.125.269746; DOI: https://doi.org/10.2967/jnumed.125.269746
You have access
Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
Cigdem Soydal, Mine Araz, Burak Demir, Tunc Ones, Kerim Sonmezoglu, Nalan Alan Selcuk, Tugsan Balli, Emine Goknur Isık, Bilge Volkan Salancı, Erkan Derebek, Selin Kesim, Onur Erdem Sahin, Ferhat Can Piskin, Emre Can Celebioglu, Mehmet Sadik Bilgic and Nuriye Ozlem Kucuk

Journal of Nuclear Medicine May 22, 2025, jnumed.125.269519; DOI: https://doi.org/10.2967/jnumed.125.269519

Featured Articles

MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy

May 01, 2025
¹⁷⁷Lu-DOTATATE in Combination with PARP Inhibitor Olaparib Is Feasible in Patients with...

May 01, 2025
Treatment Landscape of Prostate Cancer in the Era of PSMA Radiopharmaceutical Therapy

May 01, 2025
RECIP 1.0: A Roadmap for Clinical Implementation

May 01, 2025
Imaging the Activity of Efflux Transporters at the Blood–Brain Barrier in Neurologic Diseases:...

May 01, 2025
Is ²¹¹At Really Happening?

May 01, 2025
A Brief Report on the Results of the 2024 National Survey of Nuclear Medicine Conducted by the...

May 01, 2025
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine...

May 01, 2025
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory...

May 01, 2025

About The Journal of Nuclear Medicine

The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research.